Miejsce:
Online
Data:
7-9 października 2021
09:15
14th International Cardiovascular Reasearch Meeting
Konferencja pod patronatem Oddziału Bydgoskiego Polskiego Towarzystwa Kardiologicznego
PROGRAM MERYTORYCZNY
Zapraszamy do zapoznania się ze szczegółami programu.
09:15 - 09:20
Opening speech
Jacek Kubica
09:20 - 09:40
Coronary revascularization plus medical therapy or medical therapy alone in elective patients with chronic coronary syndrome (Lecture of the day)
Eliano P. Navarese
09:40 - 09:45
Break
09:45 - 11:00
SESSION 1
09:45 - 10:00
Reduced hospital admissions and increased mortality for acute Heart Failure during COVID-19 pandemic in Poland: a multicentre study (HF-COV-SIRIO 6 study)
Małgorzata Ostrowska
10:00 - 10:15
Predictors of in-hospital clinical outcome in COVID-19 patients
Klaudyna Grzelakowska
10:15 - 10:30
Determinants of anti-SARS-CoV-2 antibodies after vaccination
Magdalena Krintus
10:30 - 10:45
IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the COVID-19 (The IMPACT COVID 19 - SIRIO 5 randomized study)
Jacek Kubica
10:45 - 11:00
DISCUSSION
11:00 - 11:15
Break
11:15 - 12:30
SESSION 2
11:15 - 11:30
Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines
Marco Cattaneo
11:30 - 11:45
Optimal Antithrombotic treatment in COVID-19 Patients
Giuseppe Patti
11:45 - 12:00
Biomarkers of Thrombosis in COVID-19
Diana Gorog
12:00 - 12:15
Aspirin as an Ideal Pharmacologic Therapy for COVID-19
Udaya Tantry
12:15 - 12:30
DISCUSSION
12:30 - 12:45
Break
12:45 - 14:15
SESSION 3
12:45 - 13:00
Inhaled Acetylsalicylic Acid for Immediate Platelet Inhibition
Paul A. Gurbel
13:00 - 13:15
Ethnic difference of thrombogenicity in patients with coronary artery disease
Young-Hoon Jeong
13:15 - 13:30
Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention
Jolanta Siller-Matula
13:30 - 13:45
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Andrzej Budaj
13:45 - 14:00
Mortality risk prediction in patients with cardiogenic shock (The CardShock study)
Salvatore di Somma
14:00 - 14:15
DISCUSSION
14:15 - 16:15
SESSION 4 - ELECTRA trial investigators meeting
09:00 - 09:20
PCSK9 vaccine – a future therapeutic option or illusory hopes (Lecture of the day)
Maciej Banach
09:20 - 09:30
Break
09:30 - 11:00
SESSION 6
09:30 - 09:45
Acute coronary syndromes in elderly patients
Stefano De Servi
09:45 - 10:00
Cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction (The COOL AMI EU Pivotal Trial)
Marko Noc
10:00 - 10:15
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention (The TWILIGHT Trial)
Robert Gil
10:15 - 10:30
Resorbable Magnesium Scaffold in ACS patients
Magdalena Łanocha
10:30 - 10:45
Baseline electrocardiographic predictors of Left Ventricular Remodeling in STEMI
Tomasz Fabiszak
10:45 - 11:00
DISCUSSION
11:00 - 11:15
Break
11:15 - 12:30
SESSION 7
11:15 - 11:30
Rivaroxaban in Peripheral Artery Disease (The VOYAGER PAD Trial)
Marc Bonaca
11:30 - 11:45
Venous Thromboembolism in cancer patients
Adam Torbicki
wykład sponsorowany przez firme Pfizer
11:45 - 12:00
Percutaneous mechanical thrombectomy in patients with high-risk pulmonary embolism and contraindications for thrombolytic therapy
Klemen Steblovnik
12:00 - 12:15
Transcriptomic Profiling of Femoral Veins in Deep Vein Thrombosis in a Porcine Model
Leszek Gromadziński
12:15 - 12:30
DISCUSSION
12:30 - 12:45
Break
12:45 - 14:15
SESSION 8
12:45 - 13:00
NCU-AF: on-line qualification for ablation of atrial fibrillation and left atrial appendage occlusion
Piotr Adamski
13:00 - 13:15
Management of patients with coronary artery disease in Lithuania
Jolita Badariene
13:15 - 13:30
Outcomes of managed care in acute myocardial infarction survivors survivors
Piotr Jankowski
13:30 - 13:45
Determinants of elevated lipid parameters in patients without diagnosed car-diovascular disease - results from the polish arm of the EUROASPIRE V sur-vey
Jakub Ratajczak
13:45 - 14:00
PCSK9 inhibitors in acute coronary syndrome
Miłosz Jaguszewski
14:00 - 14:15
DISCUSSION
14:15 - 14:30
Break
14:30 - 15:45
SESSION 9
14:30 - 14:45
Impact of COVID-19 on clinical outcome in acute coronary syndrome patients
Wojciech Wojakowski
14:45 - 15:00
Renal injury in patients admitted due to Covid-19 – single centre experience
Małgorzata Jasiewicz
15:00 - 15:15
Electrotherapy in the COVID-19 era in Poland
Jarosław Kaźmierczak
15:15 - 15:30
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
Marek Postuła
15:30 - 15:45
DISCUSSION
15:45 - 17:00
SIRIO MEDICINE network meeting
09:00 - 09:20
On the Shades of Coronary Calcium and Plaque Instability - (Lecture of the day)
Eloisa Arbustini
09:20 - 09:30
Break
09:30 - 11:00
SESSION 11
09:30 - 09:45
Levosimendan improves the acute course of takotsubo syndrome
Miłosz Jaguszewski
09:45 - 10:00
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Fail-ure and Reduced Ejection Fraction
Jarosław Drożdż
10:00 - 10:15
Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock (CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry)
Przemysław Trzeciak
10:15 - 10:30
Long-term outcomes following drug-eluting balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis (DEB-Dragon-Registry)
Piotr Niezgoda
10:30 - 10:45
The impact of the COVID-19 pandemic on the functioning of the emergency medical service
Michał Kasprzak
10:45 - 11:00
DISCUSSION
11:00 - 11:15
Closing remarks
Jacek Kubica
